Abiogen Pharma’s marketing activity aims at maximizing the results of its drugs and affirming its licensed products. It is the leading company on the market for bone metabolism thanks to the marketing of the four Bisphosphonates (Etidron, Clasteon Alendros and Nerixia) fruit of its Research Centre.

Gladio (Aceclophenac) also lies in this field, a new anti-inflammatory.

The company is strongly involved in the respiratory therapeutic area, with Broncho-Munal, a highly specialized bioengineered product obtained from bacterial lisates with low molecular weight and Bornilene. These products have consented Abiogen Pharma to develop a tight collaboration with Paediatricians and Pneumatologists.